Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0002874 (aplastic anemia)
 5,905 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Nine isolates of Escherichia coli were recovered from seven blood cultures over a period of 3 months from a 19-month-old female with aplastic anemia. Initial isolates were susceptible to extended-spectrum cephalosporins, including ceftazidime (MIC, < or = 0.25 microgram/ml), but gradually became resistant to this drug (MICs, > or = 128 micrograms/ml) and other cephalosporins and the monobactam aztreonam. Molecular typing methods, including plasmid profile analysis, pulsed-field gel electrophoresis, and arbitrarily primed PCR, indicated that the nine isolates were derived from a common ancestor. Dot blot hybridization and PCR analysis of total bacterial DNA using blaSHV- and blaTEM-specific DNA probes and primers identified the presence of a blaTEM beta-lactamase gene in all of the isolates and a blaSHV gene in the isolates with elevated ceftazidime MICs. Isoelectric focusing analysis of crude lysates showed that all nine isolates contained an enzyme with a pI of 5.4 corresponding to the TEM-1 beta-lactamase, and those isolates containing an SHV-type beta-lactamase demonstrated an additional band with a pI of 7.6. The first of the ceftazidime-resistant isolates appeared to hyperproduce the SHV enzyme compared to the other resistant isolates. DNA sequencing revealed a blaSHV-1 gene in the first ceftazidime-resistant isolate and a novel blaSHV gene, blaSHV-8, with an Asp-to-Asn substitution at amino acid position 179 in the remaining four isolates. Three of the ceftazidime-resistant isolates also showed a change in porin profile. The patient had received multiple courses of antimicrobial agents during her illness, including multiple courses of ceftazidime. This collection of blood isolates from the same patient appears to represent the in vivo evolution of resistance under selective pressure of treatment with various cephalosporins.
 ...
PMID:Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. 905 8

In this work, silver-doped TiO2 (Ag/TiO2) nanoparticles were synthesized using a photodeposition technique. The prepared Ag/TiO2 nanoparticles were characterized using TEM, SEM, XRD, and EDX techniques. The characterization of Ag/TiO2 nanoparticles using SEM and EDX techniques revealed the dispersion of Ag metal on the surface of TiO2. The photocatalytic activity of Ag/TiO2 and bare TiO2 in the presence of ultraviolet irradiation was investigated in the removal of chloramphenicol (CAP) as an antibiotic. CAP is a broad-spectrum antibiotic exhibiting activity against both Gram-positive and Gram-negative bacteria, as well as other groups of microorganisms. However, it is, in certain susceptible individuals, associated with serious toxic effects in humans including bone marrow depression, particularly severe in the form of fatal aplastic anaemia. The effects of the operational factors, such as doping content of Ag, photocatalyst dosage and calcination temperature were evaluated in the catalytic activity of Ag/TiO2. The results showed that the photocatalytic efficiency of TiO2 nanoparticles for the degradation of CAP, can be significantly improved by deposition an optimum amount of Ag nanoparticles (0.96 wt%) in the calcination temperature 300 degrees C. It was found that 900 mg/L of Ag/TiO2 is the optimum dosage in the removal of CAP with 20 mg/L initial concentration. The highest removal efficiency of CAP (-100%) at the optimum conditions was observed in 20 min. A mineralization study under optimum conditions showed about 88% reduction in total organic carbon after 120 min of irradiation time.
 ...
PMID:Photocatalytic degradation of chloramphenicol in an aqueous suspension of silver-doped TiO2 nanoparticles. 2419 48